Escalon Medical

ESMC · OTC

$0.183+$0.013 (+7.65%)TodayMarket closed ·
Prev close $0.17

About ESMC

Escalon Medical Corp. engages in the development, manufacture, marketing, and distribution of medical devices for ophthalmic applications. The company is headquartered in Wayne, Pennsylvania and currently employs 39 full-time employees. The firm and its products are subject to regulation and inspection by the United States Food and Drug Administration. Its products are A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs and AXIS Image Management. A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. UBM is a high frequency/high resolution ultrasound device. AXIS Image Management system manages ophthalmic diagnostic images via a Web browser from any device regardless of modality, device manufacturer or location.

Employees
39
Headquarters
Wayne, Pennsylvania
Listed
Sep 11, 1992
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Escalon Medical executives
NameTitleSince
Richard DePiano—1996
Mark Wallace——
John Dogum——
David Jacovini——
C. Todd Trusk——
Fred Choate——
Lisa Napolitano——

Revenue by product and region

Fiscal year ended Jun 30, 2020: $9.40M total revenue

By region

  • Domestic [Member]$5.78M61.5%
  • International [Member]$3.62M38.5%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Escalon Medical suppliers and customers
CompanyRelationshipCorrelation
Tokai CarbonSupplier and customer0.56
Air Liquide AI.PASupplier-0.47

Similar companies

Companies in the same industry as Escalon Medical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.